{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T02:22:23Z","timestamp":1788056543816,"version":"build-2784847793"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["16dm0107100h001"],"award-info":[{"award-number":["16dm0107100h001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["15dK0310061h001"],"award-info":[{"award-number":["15dK0310061h001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.bbrc.2018.02.131","type":"journal-article","created":{"date-parts":[[2018,2,15]],"date-time":"2018-02-15T22:04:48Z","timestamp":1518732288000},"page":"683-688","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Increased cerebrospinal fluid complement C5 levels in major depressive disorder and schizophrenia"],"prefix":"10.1016","volume":"497","author":[{"given":"Takashi","family":"Ishii","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kotaro","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Miyakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7541-2075","authenticated-orcid":false,"given":"Shinsuke","family":"Hidese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3450-7283","authenticated-orcid":false,"given":"Daimei","family":"Sasayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miho","family":"Ota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiya","family":"Teraishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Hori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumiko","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Nunomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyuki","family":"Nakagome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kunugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2018.02.131_bib1","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/1741-7015-11-126","article-title":"Toward the future of psychiatric diagnosis: the seven pillars of RDoC","volume":"11","author":"Cuthbert","year":"2013","journal-title":"BMC Med."},{"key":"10.1016\/j.bbrc.2018.02.131_bib2","doi-asserted-by":"crossref","first-page":"11412","DOI":"10.1038\/srep11412","article-title":"Increased cerebrospinal fluid fibrinogen in major depressive disorder","volume":"5","author":"Hattori","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2018.02.131_bib3","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/mp.2016.3","article-title":"A\u00a0meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression","volume":"21","author":"Goldsmith","year":"2016","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.bbrc.2018.02.131_bib4","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.jpsychires.2011.06.003","article-title":"Association of plasma IL-6 and soluble IL-6 receptor levels with the Asp358Ala polymorphism of the IL-6 receptor gene in schizophrenic patients","volume":"45","author":"Sasayama","year":"2011","journal-title":"J.\u00a0Psychiatr. Res."},{"key":"10.1016\/j.bbrc.2018.02.131_bib5","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S2215-0366(14)00122-9","article-title":"Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment","volume":"2","author":"Khandaker","year":"2015","journal-title":"The Lancet. Psychiatry"},{"key":"10.1016\/j.bbrc.2018.02.131_bib6","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jpsychires.2012.12.001","article-title":"Increased cerebrospinal fluid interleukin-6 levels in patients with schizophrenia and those with major depressive disorder","volume":"47","author":"Sasayama","year":"2013","journal-title":"J.\u00a0Psychiatr. Res."},{"key":"10.1016\/j.bbrc.2018.02.131_bib7","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/schbul\/sbx035","article-title":"Meta-analysis of cerebrospinal fluid cytokine and tryptophan catabolite alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder, and depression","volume":"44","author":"Wang","year":"2018","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.bbrc.2018.02.131_bib8","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/ncomms2230","article-title":"Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation","volume":"3","author":"Davalos","year":"2012","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2018.02.131_bib9","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jneuroim.2012.09.002","article-title":"Increase of complement fragment C5a in cerebrospinal fluid during exacerbation of neuromyelitis optica","volume":"254","author":"Kuroda","year":"2013","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.bbrc.2018.02.131_bib10","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s12017-009-8085-y","article-title":"The role of the complement system and the activation fragment C5a in the central nervous system","volume":"12","author":"Woodruff","year":"2010","journal-title":"NeuroMolecular Med."},{"key":"10.1016\/j.bbrc.2018.02.131_bib11","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nature16549","article-title":"Schizophrenia risk from complex variation of complement component 4","volume":"530","author":"Sekar","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2018.02.131_bib12","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.neuron.2014.12.020","article-title":"Anterograde C1ql1 signaling is required in order to determine and maintain a single-winner climbing fiber in the mouse cerebellum","volume":"85","author":"Kakegawa","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.bbrc.2018.02.131_bib13","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/npp.2017.164","article-title":"Complement gene expression correlates with superior frontal cortical thickness in humans","volume":"43","author":"Allswede","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbrc.2018.02.131_bib14","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1590\/2237-6089-2015-0088","article-title":"Frontal lobe alterations in schizophrenia: a review","volume":"38","author":"Mubarik","year":"2016","journal-title":"Trends Psychiatr. Psychother."},{"key":"10.1016\/j.bbrc.2018.02.131_bib15","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/pcn.12560","article-title":"Association between the scores of the Japanese version of the Brief Assessment of Cognition in Schizophrenia and whole-brain structure in patients with chronic schizophrenia: a voxel-based morphometry and diffusion tensor imaging study","volume":"71","author":"Hidese","year":"2017","journal-title":"Psychiatr. Clin. Neurosci."},{"issue":"Suppl 20","key":"10.1016\/j.bbrc.2018.02.131_bib16","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J.\u00a0Clin. Psychiatr."},{"key":"10.1016\/j.bbrc.2018.02.131_bib17","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.bbrc.2018.02.131_bib18","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/YIC.0b013e3282f948f5","article-title":"The GRID-HAMD: standardization of the Hamilton depression rating scale","volume":"23","author":"Williams","year":"2008","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.bbrc.2018.02.131_bib19","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A\u00a0rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.bbrc.2018.02.131_bib20","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/pcn.12275","article-title":"Psychotropic dose equivalence in Japan","volume":"69","author":"Inada","year":"2015","journal-title":"Psychiatr. Clin. Neurosci."},{"key":"10.1016\/j.bbrc.2018.02.131_bib21","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1097\/JGP.0b013e3180547091","article-title":"The relationship between cerebrospinal fluid biomarkers and depression in elderly women","volume":"15","author":"Gudmundsson","year":"2007","journal-title":"Am. J. Geriatr. Psychiatr."},{"key":"10.1016\/j.bbrc.2018.02.131_bib22","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jpsychires.2009.08.008","article-title":"Cerebrospinal fluid analysis in affective and schizophrenic spectrum disorders: identification of subgroups with immune responses and blood-CSF barrier dysfunction","volume":"44","author":"Bechter","year":"2010","journal-title":"J.\u00a0Psychiatr. Res."},{"key":"10.1016\/j.bbrc.2018.02.131_bib23","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0165-0327(00)00321-9","article-title":"S-100B is increased in melancholic but not in non-melancholic major depression","volume":"66","author":"Rothermundt","year":"2001","journal-title":"J.\u00a0Affect. Disord."},{"key":"10.1016\/j.bbrc.2018.02.131_bib24","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1097\/00001756-200209160-00021","article-title":"S100B is increased in mood disorders and may be reduced by antidepressive treatment","volume":"13","author":"Schroeter","year":"2002","journal-title":"Neuroreport"},{"key":"10.1016\/j.bbrc.2018.02.131_bib25","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4306\/pi.2008.5.3.193","article-title":"Serum S100B levels and major depressive disorder: its characteristics and role in antidepressant response","volume":"5","author":"Jang","year":"2008","journal-title":"Psychiatry Investig."},{"key":"10.1016\/j.bbrc.2018.02.131_bib26","article-title":"S100B serum levels predict treatment response in patients with melancholic depression","volume":"19","author":"Ambree","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.bbrc.2018.02.131_bib27","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S2215-0366(17)30293-6","article-title":"The blood-brain barrier in psychosis","volume":"5","author":"Pollak","year":"2018","journal-title":"The lancet. Psychiatry"},{"key":"10.1016\/j.bbrc.2018.02.131_bib28","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.brainres.2014.08.011","article-title":"Adverse effects of antipsychotics on micro-vascular endothelial cells of the human blood-brain barrier","volume":"1583","author":"Elmorsy","year":"2014","journal-title":"Brain Res."},{"key":"10.1016\/j.bbrc.2018.02.131_bib29","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1016\/j.euroneuro.2015.08.004","article-title":"Microglial activation in the rat brain following chronic antipsychotic treatment at clinically relevant doses","volume":"25","author":"Cotel","year":"2015","journal-title":"Eur. Neuropsychopharmacol"},{"key":"10.1016\/j.bbrc.2018.02.131_bib30","first-page":"210","article-title":"Complement C5a receptor knockout has diminished light-induced microglia\/macrophage retinal migration","volume":"23","author":"Song","year":"2017","journal-title":"Mol. Vis."},{"key":"10.1016\/j.bbrc.2018.02.131_bib31","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12974-015-0369-6","article-title":"Active immunization against complement factor C5a: a new therapeutic approach for Alzheimer's disease","volume":"12","author":"Landlinger","year":"2015","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.bbrc.2018.02.131_bib32","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature05485","article-title":"Inflammation and metabolic disorders","volume":"444","author":"Hotamisligil","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2018.02.131_bib33","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1146\/annurev-immunol-031210-101322","article-title":"Inflammatory mechanisms in obesity","volume":"29","author":"Gregor","year":"2011","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.bbrc.2018.02.131_bib34","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.bbi.2016.10.020","article-title":"The effect of systemic inflammation on human brain barrier function","volume":"62","author":"Elwood","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbrc.2018.02.131_bib35","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1093\/gerona\/glt177","article-title":"Obesity in aging exacerbates blood-brain barrier disruption, neuroinflammation, and oxidative stress in the mouse hippocampus: effects on expression of genes involved in beta-amyloid generation and Alzheimer's disease","volume":"69","author":"Tucsek","year":"2014","journal-title":"J.\u00a0Gerontol. A Biol. Sci. Med. Sci"},{"key":"10.1016\/j.bbrc.2018.02.131_bib36","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1001\/archgenpsychiatry.2010.2","article-title":"Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies","volume":"67","author":"Luppino","year":"2010","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.bbrc.2018.02.131_bib37","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.neubiorev.2014.12.017","article-title":"Is there a \u201cmetabolic-mood syndrome\u201d? A review of the relationship between obesity and mood disorders","volume":"52","author":"Mansur","year":"2015","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bbrc.2018.02.131_bib38","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/pcn.12299","article-title":"Biochemical markers subtyping major depressive disorder","volume":"69","author":"Kunugi","year":"2015","journal-title":"Psychiatr. Clin. Neurosci."},{"key":"10.1016\/j.bbrc.2018.02.131_bib39","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1126\/science.1088417","article-title":"Inflammatory blockade restores adult hippocampal neurogenesis","volume":"302","author":"Monje","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2018.02.131_bib40","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1038\/nbt1342","article-title":"Complement-targeted therapeutics","volume":"25","author":"Ricklin","year":"2007","journal-title":"Nat. Biotechnol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X18303620?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X18303620?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T11:23:02Z","timestamp":1757762582000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X18303620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0006291X18303620"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2018.02.131","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased cerebrospinal fluid complement C5 levels in major depressive disorder and schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2018.02.131","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}